Follow the Newron Pharmaceuticals S.p.A. stock price and the full management transaction log of the company, a listed issuer based in Switzerland. Shares are quoted on the CH market, under the supervision of SIX SER. Operating in the Health Care sector, Newron Pharmaceuticals S.p.A. has published 13 insider filings. Market capitalisation: €269.6m. The latest transaction was filed on 12 August 2026 (Purchase). All data is openly available.
13
Insider Decl.
n/a
Thresholds
€266,768
10 ops.
Buy Volume
€487,256
3 ops.
Sell Volume
24Σ signal
Buys €266,768€487,256 Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 12 August 2026
Declarations13 total
●
Anonymous (an executive member of the board of directors / member of senior management)
an executive member of the board of directors / member of senior management·Executives·(filed)